What is the specific role of ANT2 in cancer cells?;Quel rôle spécifique pour ANT2 dans une cellule cancéreuse?

Medecine/Sciences

Volumn 21, Issue 2, 2005, Pages 156-161

  Chevrollier, Arnaud ^a   Leiseau, Dominique ^b   Stepien, Georges ^a  

^a INSERM   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CISPLATIN; HEXOKINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

APOPTOSIS; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; DRUG TARGETING; GLYCOLYSIS; HUMAN; INTRACELLULAR TRANSPORT; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; REVIEW; RNA INTERFERENCE; TRANSPORT KINETICS;

FORMICIDAE;

EID: 13944278753     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005212156     Document Type: Review

References (26)

1. Capaldi RA, Halphen DG, Zhang XZ, Yanamura W. Complexity and tissue specificity of the mitochondrial respiratory chain. J Bioenerg Biomembr 1988; 20: 291-311.
2. Pebay-Peyroula E, Dahout-Gonzalez C, Kahn R, et al. Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 2003; 426: 39-44.
3. Stepien G, Torroni A, Chung A, et al. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during cell differentiation. J Biol Chem 1992; 267: 14592-7.
4. Li K, Hodge JA, Wallace DC. DXBDX, a positive transcriptional element of the heart-skeletal muscle ADP/ATP translocator gene. J Biol Chem 1990; 265: 20585-8.
5. Giraud S, Bonod-Bidaud C, Wesolowski-Louvel M, Stepien G. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J Mol Biol 1998; 281: 409-18.
6. Luciakova K, Barath P, Poliakova D, et al. Repression of the human adenine nucleotide translocase-2 gene in growth-arrested human diploid cells: the role of nuclear factor-1. J Biol Chem 2003; 278: 30624-33.
7. Ku DH, Kagan J, Chen ST, et al. The human fibroblast adenine nucleotide translocator gene: molecular cloning and sequence. J Biol Chem 1990; 265: 16060-3.
8. Barath P, Luciakova K, Hodny Z, et al. The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription and is a marker of cell proliferation. Exp Cell Res 1999; 248: 583-8.
9. Jang JY, Lee CE. Mitochondrial adenine nucleotide translocator 3 is regulated by IL-4 and IFN-gamma via STAT-dependent pathways. Cell Immunol 2003; 226: 11-9.
10. Amiri H, Karlberg O, Andersson SE. Deep origin of plastid/parasite ATP/ADP translocases. J Mol Evol 2003; 56: 137-50.
11. Mathupala SP, Rempel A, Pedersen PL. Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 2001; 276: 43407-12.
12. Pedersen PL, Mathupala S, Rempel A, et al. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta 2002; 1555: 14-20.
13. Napoli L, Bordoni A, Zeviani M, et al. A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. Neurology 2001; 57: 2295-8.
14. Siciliano G, Tessa A, Petrini S, et al. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANTI gene. Neuromuscul Disord 2003; 13: 162-5.
15. Jordens EZ, Palmieri L, Huizing M, et al. Adenine nucleotide translocator 1 deficiency associated with Sengers syndrome. Ann Neurol 2002; 52: 95-9.
16. Graham BH, Waymire KG, Cottrell B, et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997; 16: 226-34.
17. Faustin B, Rossignol R, Rocher C, et al. Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem 2004; 279: 20411-21.
18. Kokoszka JE, Waymire KG, Levy SE, et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004; 427: 461-5.
19. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997; 18: 44-51.
20. Brenner C, Cadiou H, Vieira HL, et al. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 2000; 19: 329-36.
21. Bauer MK, Schubert A, Rocks O, Grimm S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 1999; 147: 1493-502.
22. Zamora M, Granell M, Mampel T, Vinas O. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Lett 2004; 563: 155-160.
23. Ara G, Kusumoto T, Korbut TT, et al. Cis-diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtC14(Rh-123)2: evidence for mitochondrial involvement. Cancer Res 1994; 54: 1497-502.
24. Harper ME, Antoniou A, Villalobos-Menuey E, et al. Characterization of a novel metabolic strategy used by drug-resistant tumor cells. FASEB J 2002; 16: 1550-7.
25. Ludwig B, Bender E, Arnold S, et al. Cytochrome C oxidase and the regulation of oxidative phosphorylation. Chem Biochem 2001; 2: 392-403.
26. Chevrollier A, Loiseau D, Gautier F, et al. ANT2 expression under hypoxic conditions produces opposite cell-cycle behavior in 143B and HepG2 cancer cells. Mol Carcinogen 2005; 42: 1-8.